U.S. health and trade authorities this week issued a record seven warning letters in a single day to companies making CBD, the biggest federal action against the industry in over a year. Warning letters from the Food and Drug Administration and the Federal Trade Commission targeted companies making COVID-related claims. It was the first time
Federal Trade Commission
Hemp businesses walk a fine line when describing the health benefits of their products: Make a claim without evidence or wording that misleads consumers, and soon the legal fees will pile up. The U.S. Food and Drug Administration has guidelines for acceptable claims to make on labels for dietary supplements – the closest fit for